Your prescription will expire on . Renew your prescription now.

Continue Shopping
${ cart.content.item_count } Cart

TORONTO and MISSISSAUGA, Ontario, Dec. 13, 2018 (GLOBE NEWSWIRE) -- The Green Organic Dutchman Holdings Ltd. (the "Company" or "TGOD") (TSX:TGOD) (US:TGODF) and HelloMD, a leading online cannabis healthcare company, are pleased to announce a partnership to streamline TGOD’s medical cannabis onboarding experience.

TGOD will begin selling its premium, certified-organic cannabis to medical patients in late January 2019. The integration of HelloMD's convenient online clinic services will enhance TGOD’s best-in-class approach to patient care.

HelloMD provides a solution for patients looking to conveniently access medical cannabis in Canada online. By leveraging HelloMD’s white-label patient services platform, TGOD will ensure patients have convenient access to independent, practitioner-led advice and education about medical cannabis. Prospective patients can connect online with a licensed practitioner seven days a week from the comfort of their preferred location. Patients who obtain appropriate documentation can purchase from TGOD’s broad range of premium medical cannabis products.

“At TGOD, “Making Life Better” is not just our brand tagline, it’s our ongoing commitment to every consumer,” said Andrew Pollock, Vice President of Marketing at TGOD. “Patients deserve premium organic cannabis and through the partnership with HelloMD, we are pleased to provide increased access to TGOD’s product lines with the highest level of customer service and functionality to our patients.”

“The journey from canna-curious, to feeling better, can be complex for Canadians considering medical cannabis,” said Larry Lisser, SVP of Business Development at HelloMD. “HelloMD’s services enable our partners to improve their patients’ experience by streamlining the onboarding process. In this joint effort with TGOD, we will ensure patients receive the best personalized advice on organic medical cannabis to move forward.”

To become a TGOD patient, click here.

For Media Inquiries:

HelloMD: Garrett Repski, Project Manager, Marigold Marketing & PR, 1-647-972-2466,

TGOD: Andrew Pollock, Vice President, Marketing, 905-304-4201,

About HelloMD: 
HelloMD has facilitated more than 100,000 virtual consults between medical cannabis patients and licensed practitioners. The company’s white-label solutions enable third parties to quickly deploy a turnkey telehealth solution, complete with the technology, practitioners and support personnel required to improve their own patient onboarding processes. 
For further information about HelloMD:

The Green Organic Dutchman Holdings Ltd. is a research & development company licensed under the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) to cultivate medical cannabis. The Company carries out its principal activities producing cannabis from its facilities in Ancaster, Ont., pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada) and its regulations.

The Company grows high quality, organic cannabis with sustainable, all-natural principles. TGOD's products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a funded capacity of 170,000 kg of cultivation facilities in Ontario and Quebec and Jamaica. 

TGOD’s Common Shares and warrants issued under the indenture dated November 1, 2017 trade on the TSX under the symbol "TGOD" and “TGOD.WT”, respectively.

Investor Relations
Phone: 1 (416) 900-7621

Forward-Looking Information Cautionary Statement

This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward looking statements in this release includes, but is not limited to, statements about the future legalization of recreational cannabis and cannabis-infused products in Canada, statements about future research, development and innovation by the Company, statements about the offering of any particular products by the Company in any particular territory and statements regarding the future performance of the Company. Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable law.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of Toronto Stock Exchange) accept responsibility for the adequacy or accuracy of this release.